News

Two Cardiff cancer researchers awarded Springboard grants from Academy of Medical Sciences

10 April 2025

Two researchers based at Cardiff University’s Systems Immunity Research Institute have been recognised through the Academy of Medical Sciences Springboard awards.

Public encouraged to routinely test for bloodborne viruses as part of engagement project

4 March 2025

Common bloodborne diseases can be identified and treated with routine testing, animated videos show how.

New Year Honours

17 January 2025

University community recognised

Cardiff researcher awarded Future Leaders fellowship to develop smart viruses for brain cancer

16 January 2025

Dr Emily Bates of Systems Immunity Research Institute has begun working with smart viruses to find new treatments for Glioblastoma.

New anticancer T-cell type discovered

2 January 2025

Cardiff University researchers have discovered a new anticancer T-cell subtype, which could help our immune system tackle cancer in the future.

Cardiff Researcher awarded Future Leaders Fellowship from Brain Tumour Charity

8 October 2024

Dr Mathew Clement, currently based at Systems Immunity Research Institute, has been announced as one of Brain Tumour Charity’s Future Leaders 2024.

TeamCardiff at the 2024 Cardiff Half Marathon with the Vice Chancellor

Over £34k raised by #TeamCardiff runners at Cardiff Half Marathon

7 October 2024

Over 100 alumni, students, and staff ran the Principality Cardiff Half Marathon to raise funds for Cardiff University research.

Bacteria triggers type-1 diabetes

18 September 2024

Bacterial infection can induce an immune response that leads to type-1 diabetes, according to Cardiff University researchers.

BioFAIR is ready to transform data management in life sciences research

5 August 2024

Academics from Systems Immunity Research Institute and the Digital Transformation Innovation Institute are supporting a new project that seeks to democratise access to life sciences data, workflow and communities.

Child having their glucose levels tested

Psoriasis drug shows promise for treating childhood diabetes

30 July 2024

A drug commonly used to treat psoriasis, Ustekinumab, has been found to be effective in helping to treat children and adolescents with type-1 diabetes.